N-substituted benzamides inhibit NFκB activation and induce apoptosis by separate mechanisms
1999
Benzamides and Their Effects on Cell Death
publication
Author Information
Author(s): Liberg D, Lazarevic B, Pero R W, Leanderson T
Primary Institution: Lund University
Hypothesis
N-substituted benzamides can induce apoptosis and inhibit NFκB activation through separate mechanisms.
Conclusion
N-substituted benzamides can induce early apoptosis and inhibit NFκB activation, suggesting their potential as sensitizers in cancer treatment.
Supporting Evidence
- Procainamide was biologically inert, while declopramide induced rapid apoptosis.
- Declopramide inhibited NFκB activation by preventing IκBβ breakdown.
- N-acetyl declopramide was a potent inhibitor of NFκB activation but did not induce apoptosis.
Takeaway
Some special chemicals called benzamides can help kill cancer cells and stop them from escaping death.
Methodology
The study analyzed the mechanisms of action of N-substituted benzamides using an in vitro system.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website